| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000032626 |
| Receipt No. | R000037201 |
| Scientific Title | Effect of skin cleansing foam on skin condition |
| Date of disclosure of the study information | 2018/05/18 |
| Last modified on | 2020/03/23 (Ver. 3) |
| Basic information | ||
| Public title | Effect of skin cleansing foam on skin condition | |
| Acronym | Effect of skin cleansing foam on skin condition | |
| Scientific Title | Effect of skin cleansing foam on skin condition | |
| Scientific Title:Acronym | Effect of skin cleansing foam on skin condition | |
| Region |
|
|
| Condition | ||
| Condition | Healthy adult female | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Evaluate changes in skin condition when an adult female uses cleansing foam for 4 weeks |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Comparison of skin condition before starting use of test article and 4 weeks after use, comparison of skin condition of test group use group and placebo use group |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Using cleansing foam for 4 consecutive weeks | |
| Interventions/Control_2 | 4 weeks use of facial cleansing foam with a shape similar to the specimen generally sold | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1. Female between 30 and 60 years of age inclusive
2. Subjects who care about the condition of the skin from day to day |
|||
| Key exclusion criteria | 1. Subjects with cosmetic allergies
2. Subjects who are pregnant or lactating 3. Subjects with inflamed or scraped skin on face 4. Subjects who are judged as unsuitable for the study by the investigator for the other reason |
|||
| Target sample size | 18 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Japan Clinical Trial Association | ||||||
| Division name | N.A. | ||||||
| Zip code | |||||||
| Address | 5F, 4-3-17 Shinjuku, Shinjukuku, Tokyo | ||||||
| TEL | 0364574666 | ||||||
| info@yakujihou.org | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Japan Clinical Trial Association | ||||||
| Division name | N.A. | ||||||
| Zip code | |||||||
| Address | 5F, 4-3-17 Shinjuku, Shinjukuku, Tokyo | ||||||
| TEL | 0364574666 | ||||||
| Homepage URL | |||||||
| info@yakujihou.org | |||||||
| Sponsor | |
| Institute | Japan Clinical Trial Association |
| Institute | |
| Department | |
| Funding Source | |
| Organization | RISOU Co., Ltd |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037201 |